Voluntary Sodium Reduction Goals: Target Mean and Upper Bound Concentrations for Sodium in Commercially Processed, Packaged, and Prepared Foods; Draft Guidance for Industry (Edition 2); Availability, 66727-66729 [2024-18261]
Download as PDF
66727
Federal Register / Vol. 89, No. 159 / Friday, August 16, 2024 / Notices
the goal and mission of the program has
evolved with each funding cycle. The
2021–2024 funding cycle is the first
such initiative to focus on addressing
health equity specifically and
understanding efforts to impact stroke
outcomes for those at highest risk of
stroke. CDC proposes to continue
collecting information from thirteen
funded PCNASP recipients to gain
insight into the effectiveness of
implementation approaches, including
linking and using data, using teambased
approaches to coordinate stroke care,
and providing community resources in
order to reach the general population
and those at highest risk of stroke
events, and reduce disparities in access
to quality care for high burden
populations. The insights to be gained
from this continuing data collection will
be critical to improving immediate
efforts and achieving the goals of
spreading and replicating State-level
strategies that are proven
programmatically and are cost-effective
in contributing to a higher quality of
care for stroke patients.
CDC requests OMB approval for an
estimated 501 annual burden hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN (HOURS)
Type of respondents
Form name
PCNASP Awardee ...........................
Pre-Hospital data ..........................................................
PCNASP Hospital Partners ..............
In-Hospital data .............................................................
Hospital Inventory (awardees) ......................................
Hospital Inventory for Hospital Partners .......................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–18374 Filed 8–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
In accordance with 5 U.S.C. 1009(d),
the Centers for Disease Control and
Prevention (CDC) announces the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Dates: October 23–24, 2024.
Times: 11 a.m.–5 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
Study Section to consider safety and
occupational health-related grant
applications.
VerDate Sep<11>2014
17:33 Aug 15, 2024
Jkt 262001
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26505. Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–18434 Filed 8–15–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
3
10
13
13
650
Number of
responses per
respondent
Average
burden
per
response
(in hours)
4
4
4
1
1
30/60
1
30/60
8
30/60
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–D–0055]
Voluntary Sodium Reduction Goals:
Target Mean and Upper Bound
Concentrations for Sodium in
Commercially Processed, Packaged,
and Prepared Foods; Draft Guidance
for Industry (Edition 2); Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of a draft
guidance for industry entitled
‘‘Voluntary Sodium Reduction Goals:
Target Mean and Upper Bound
Concentrations for Sodium in
Commercially Processed, Packaged, and
Prepared Foods (Edition 2).’’ The draft
guidance, when finalized, will describe
our views on the next voluntary goals
(Phase II (3-year)) for sodium reduction
in a variety of identified categories of
foods that are commercially processed,
packaged, or prepared. These goals are
intended to address the excessive intake
of sodium in the current population to
help reduce the burden of diet-related
chronic disease, promote improvements
in public health, and advance health
equity by supporting a healthier food
supply.
DATES: Submit either electronic or
written comments on the draft guidance
by November 14, 2024 to ensure that we
consider your comment on the draft
SUMMARY:
E:\FR\FM\16AUN1.SGM
16AUN1
66728
Federal Register / Vol. 89, No. 159 / Friday, August 16, 2024 / Notices
guidance before we begin work on the
final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
lotter on DSK11XQN23PROD with NOTICES1
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2014–D–0055 for ‘‘Voluntary Sodium
Reduction Goals: Target Mean and
Upper Bound Concentrations for
Sodium in Commercially Processed,
Packaged, and Prepared Foods (Edition
2).’’ Received comments will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
VerDate Sep<11>2014
17:33 Aug 15, 2024
Jkt 262001
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ We
will review this copy, including the
claimed confidential information, in our
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the draft guidance to the Office
of Food Additive Safety, Center for Food
Safety and Applied Nutrition, Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740. Send two selfaddressed adhesive labels to assist that
office in processing your request. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance.
FOR FURTHER INFORMATION CONTACT:
Kasey Heintz, Center for Food Safety
and Applied Nutrition, Office of Food
Additive Safety, Food and Drug
Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–1376;
or Holli Kubicki, Center for Food Safety
and Applied Nutrition, Office of
Regulations and Policy, Food and Drug
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–2378.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of
a draft guidance for industry entitled
‘‘Voluntary Sodium Reduction Goals:
Target Mean and Upper Bound
Concentrations for Sodium in
Commercially Processed, Packaged, and
Prepared Foods (Edition 2).’’ We are
issuing the draft guidance consistent
with our good guidance practices
regulation (21 CFR 10.115). The draft
guidance, when finalized, will represent
the current thinking of FDA on this
topic. It does not establish any rights for
any person and is not binding on FDA
or the public. You can use an alternate
approach if it satisfies the requirements
of the applicable statutes and
regulations.
Sodium is widely present in the
American diet (most commonly, but not
exclusively, as a result of eating or
drinking foods to which sodium
chloride, commonly referred to as
‘‘salt,’’ has been added). More than 70
percent of total sodium intake is from
sodium added during food
manufacturing and commercial food
preparation (Ref. 1). The average sodium
intake for those 1 year and older in the
United States is approximately 3,400
milligrams/day (mg/day) (Ref 2). The
‘‘Dietary Guidelines for Americans,
2020–2025’’ (Ref. 2) advises individuals
14 years and older to limit their
consumption to 2,300 mg/day; this
aligns with recommendations from the
National Academies of Sciences,
Engineering, and Medicine, which set
the chronic disease risk reduction intake
for sodium at 2,300 mg/day for those 14
years and older (Ref. 3). The guidance
aims to help Americans reduce average
sodium intake to 2,750 mg/day (Phase
II) by encouraging food manufacturers,
restaurants, and food service operations
to gradually reduce sodium in a wide
variety of food categories over time.
Although we recognize that a reduction
even to 2,750 mg/day still would be
higher than the recommended sodium
limit of 2,300 mg/day, the Phase II goals
are intended to balance the need for
broad and gradual reductions in sodium
and what is publicly known about
technical and market constraints on
sodium reduction and reformulation.
In the Federal Register of October 14,
2021, we announced the availability of
the final guidance for industry,
‘‘Voluntary Sodium Reduction Goals:
Target Mean and Upper Bound
Concentrations for Sodium in
Commercially Processed, Packaged, and
Prepared Foods’’ (86 FR 57156). The
E:\FR\FM\16AUN1.SGM
16AUN1
Federal Register / Vol. 89, No. 159 / Friday, August 16, 2024 / Notices
draft guidance builds on the voluntary
Phase I (2.5-year) sodium reduction
goals issued in October 2021. When
finalized, the draft guidance will
describe our views on the next
voluntary goals (Phase II (3-year)) for
sodium reduction in a variety of
identified categories of foods that are
commercially processed, packaged, or
prepared. The 3-year goals are intended
to balance the need for broad and
gradual reductions in sodium and what
is publicly known about technical and
market constraints on sodium reduction
and reformulation. The distribution of
sodium concentrations in currently
available products in each category was
a significant factor in developing these
quantitative sodium concentration
goals. We developed the goals with a
particular emphasis on maintaining
concentrations needed for food safety,
given the function of salt as a food
preservative. The Phase II goals are
within the range of concentrations
found in currently marketed foods and
are feasible using existing technical
strategies.
We note that we do not intend to
finalize the draft long-term (10-year)
sodium reduction goals that were
included in the 2016 draft of the first
edition of the guidance that we
announced in the Federal Register of
June 2, 2016 (81 FR 35363). We plan to
announce any future sodium reduction
goals via draft guidance.
lotter on DSK11XQN23PROD with NOTICES1
II. Paperwork Reduction Act of 1995
While the guidance contains no
collection of information, it does refer to
previously approved FDA collections of
information. The previously approved
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (PRA) (44 U.S.C.
3501–3521). The collections of
information in 21 CFR part 101 have
been approved under OMB control
number 0910–0381. The collections of
information in 21 CFR 101.11 have been
approved under OMB control number
0910–0782.
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at https://
www.fda.gov/FoodGuidances, https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents, or
https://www.regulations.gov. Use the
FDA website listed in the previous
sentence to find the most current
version of the guidance.
IV. References
The following references are on
display at the Dockets Management Staff
VerDate Sep<11>2014
17:33 Aug 15, 2024
Jkt 262001
(see ADDRESSES) and are available for
viewing by interested persons between
9 a.m. and 4 p.m., Monday through
Friday; they are also available
electronically at https://
www.regulations.gov. Although FDA
verified the website addresses in this
document, please note that websites are
subject to change over time.
1. Harnack L.J., M.E. Cogswell, J.M. Shikany,
et al. ‘‘Sources of Sodium in U.S. Adults
From 3 Geographic Regions.’’
Circulation, 135 (May 9, 2017): pp.
1775–1783. Available at: https://
www.ahajournals.org/doi/10.1161/
CIRCULATIONAHA.116.024446
(accessed December 26, 2023).
2. U.S. Department of Agriculture and U.S.
Department of Health and Human
Services. ‘‘Dietary Guidelines for
Americans, 2020–2025.’’ 9th Edition.
December 2020. Available at: https://
www.dietaryguidelines.gov/ (accessed
December 26, 2023).
3. National Academies of Sciences,
Engineering, and Medicine. ‘‘Dietary
Reference Intakes for Sodium and
Potassium’’ (March 2019). Washington,
DC: The National Academies Press.
Available at: https://
www.nationalacademies.org/hmd/
Reports/2019/dietary-reference-intakessodium-potassium.aspx (accessed
December 26, 2023).
Dated: August 9, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–18261 Filed 8–15–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the National Advisory
Committee on Rural Health and Human
Services
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
National Advisory Committee on Rural
Health and Human Services
(NACRHHS) has scheduled its
semiannual meeting. Information about
NACRHHS and the agenda for this
meeting can be found on the NACRHHS
website at https://www.hrsa.gov/
advisory-committees/rural-health/
index.html.
DATES: Wednesday, September 4, 2024,
9 a.m.–5 p.m. mountain daylight time
(MDT); Thursday, September 5, 2024, 9
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
66729
a.m.–5 p.m. MDT; Friday, September 6,
2024, 9 a.m.–12 p.m. MDT.
ADDRESSES: The meeting will be
conducted in two separate locations. On
September 4, 2024, the meeting will
commence at the Hilton Santa Fe
Historic Plaza Hotel, 100 Sandoval
Street, Santa Fe, New Mexico, 87501.
That afternoon, the meeting will resume
at the Historic Plaza Hotel, 230 Plaza
Street, Las Vegas, New Mexico 87701.
Telephone: (505) 425–3591. The Plaza
Hotel will be the physical location for
both the September 5 and September 6
meetings.
The meeting will also be accessible to
the public virtually via Zoom. The
meeting details are included below.
There is no need to register for this
meeting. If joining virtually, please use
the following information. This is the
link for all days of the meeting:
Join Zoom Meeting https://
us02web.zoom.us/j/81769614451.
Meeting ID: 817 6961 4451.
One tap mobile
+13052241968,,81769614451# US
+19294362866,,81769614451# US (New
York)
Dial by your location
• +1 305 224 1968 US
• +1 929 436 2866 US (New York)
• +1 301 715 8592 US (Washington, DC)
• +1 312 626 6799 US (Chicago)
• +1 669 900 6833 US (San Jose)
• +1 253 215 8782 US (Tacoma)
• +1 346 248 7799 US (Houston)
Meeting ID: 817 6961 4451.
Find your local number: https://
us02web.zoom.us/u/kcNArnR1zE.
FOR FURTHER INFORMATION CONTACT:
Sahira Rafiullah, Designated Federal
Officer of NACRHHS, 5600 Fishers
Lane, Rockville, Maryland 20857; 240–
316–5874; or srafiullah@hrsa.gov.
SUPPLEMENTARY INFORMATION:
NACRHHS provides advice and
recommendations to the Secretary of
Health and Human Services on policy,
program development, and other
matters of significance concerning both
rural health and rural human services.
At this meeting the committee will
discuss the opioid crisis and its impact
on rural families. The emphasis will be
on prevention efforts but will include
related discussions of treatment and
recovery. At this meeting, NACRHHS
will discuss the availability of disability
services in rural areas. Members of the
public will have the opportunity to
provide comments. Public participants
wishing to provide oral comments must
submit a written version of their
comments at least 3 business days in
advance of the scheduled meeting. Oral
comments will be honored in the order
they are requested and may be limited
E:\FR\FM\16AUN1.SGM
16AUN1
Agencies
[Federal Register Volume 89, Number 159 (Friday, August 16, 2024)]
[Notices]
[Pages 66727-66729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18261]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-D-0055]
Voluntary Sodium Reduction Goals: Target Mean and Upper Bound
Concentrations for Sodium in Commercially Processed, Packaged, and
Prepared Foods; Draft Guidance for Industry (Edition 2); Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
availability of a draft guidance for industry entitled ``Voluntary
Sodium Reduction Goals: Target Mean and Upper Bound Concentrations for
Sodium in Commercially Processed, Packaged, and Prepared Foods (Edition
2).'' The draft guidance, when finalized, will describe our views on
the next voluntary goals (Phase II (3-year)) for sodium reduction in a
variety of identified categories of foods that are commercially
processed, packaged, or prepared. These goals are intended to address
the excessive intake of sodium in the current population to help reduce
the burden of diet-related chronic disease, promote improvements in
public health, and advance health equity by supporting a healthier food
supply.
DATES: Submit either electronic or written comments on the draft
guidance by November 14, 2024 to ensure that we consider your comment
on the draft
[[Page 66728]]
guidance before we begin work on the final version of the guidance.
ADDRESSES: You may submit comments on any guidance at any time as
follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2014-D-0055 for ``Voluntary Sodium Reduction Goals: Target Mean and
Upper Bound Concentrations for Sodium in Commercially Processed,
Packaged, and Prepared Foods (Edition 2).'' Received comments will be
placed in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review
this copy, including the claimed confidential information, in our
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information to be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify this information as ``confidential.''
Any information marked as ``confidential'' will not be disclosed except
in accordance with 21 CFR 10.20 and other applicable disclosure law.
For more information about FDA's posting of comments to public dockets,
see 80 FR 56469, September 18, 2015, or access the information at:
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single copies of the draft guidance to
the Office of Food Additive Safety, Center for Food Safety and Applied
Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park,
MD 20740. Send two self-addressed adhesive labels to assist that office
in processing your request. See the SUPPLEMENTARY INFORMATION section
for electronic access to the draft guidance.
FOR FURTHER INFORMATION CONTACT: Kasey Heintz, Center for Food Safety
and Applied Nutrition, Office of Food Additive Safety, Food and Drug
Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1376;
or Holli Kubicki, Center for Food Safety and Applied Nutrition, Office
of Regulations and Policy, Food and Drug Administration, 5001 Campus
Dr., College Park, MD 20740, 240-402-2378.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of a draft guidance for industry
entitled ``Voluntary Sodium Reduction Goals: Target Mean and Upper
Bound Concentrations for Sodium in Commercially Processed, Packaged,
and Prepared Foods (Edition 2).'' We are issuing the draft guidance
consistent with our good guidance practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will represent the current thinking
of FDA on this topic. It does not establish any rights for any person
and is not binding on FDA or the public. You can use an alternate
approach if it satisfies the requirements of the applicable statutes
and regulations.
Sodium is widely present in the American diet (most commonly, but
not exclusively, as a result of eating or drinking foods to which
sodium chloride, commonly referred to as ``salt,'' has been added).
More than 70 percent of total sodium intake is from sodium added during
food manufacturing and commercial food preparation (Ref. 1). The
average sodium intake for those 1 year and older in the United States
is approximately 3,400 milligrams/day (mg/day) (Ref 2). The ``Dietary
Guidelines for Americans, 2020-2025'' (Ref. 2) advises individuals 14
years and older to limit their consumption to 2,300 mg/day; this aligns
with recommendations from the National Academies of Sciences,
Engineering, and Medicine, which set the chronic disease risk reduction
intake for sodium at 2,300 mg/day for those 14 years and older (Ref.
3). The guidance aims to help Americans reduce average sodium intake to
2,750 mg/day (Phase II) by encouraging food manufacturers, restaurants,
and food service operations to gradually reduce sodium in a wide
variety of food categories over time. Although we recognize that a
reduction even to 2,750 mg/day still would be higher than the
recommended sodium limit of 2,300 mg/day, the Phase II goals are
intended to balance the need for broad and gradual reductions in sodium
and what is publicly known about technical and market constraints on
sodium reduction and reformulation.
In the Federal Register of October 14, 2021, we announced the
availability of the final guidance for industry, ``Voluntary Sodium
Reduction Goals: Target Mean and Upper Bound Concentrations for Sodium
in Commercially Processed, Packaged, and Prepared Foods'' (86 FR
57156). The
[[Page 66729]]
draft guidance builds on the voluntary Phase I (2.5-year) sodium
reduction goals issued in October 2021. When finalized, the draft
guidance will describe our views on the next voluntary goals (Phase II
(3-year)) for sodium reduction in a variety of identified categories of
foods that are commercially processed, packaged, or prepared. The 3-
year goals are intended to balance the need for broad and gradual
reductions in sodium and what is publicly known about technical and
market constraints on sodium reduction and reformulation. The
distribution of sodium concentrations in currently available products
in each category was a significant factor in developing these
quantitative sodium concentration goals. We developed the goals with a
particular emphasis on maintaining concentrations needed for food
safety, given the function of salt as a food preservative. The Phase II
goals are within the range of concentrations found in currently
marketed foods and are feasible using existing technical strategies.
We note that we do not intend to finalize the draft long-term (10-
year) sodium reduction goals that were included in the 2016 draft of
the first edition of the guidance that we announced in the Federal
Register of June 2, 2016 (81 FR 35363). We plan to announce any future
sodium reduction goals via draft guidance.
II. Paperwork Reduction Act of 1995
While the guidance contains no collection of information, it does
refer to previously approved FDA collections of information. The
previously approved collections of information are subject to review by
the Office of Management and Budget (OMB) under the Paperwork Reduction
Act of 1995 (PRA) (44 U.S.C. 3501-3521). The collections of information
in 21 CFR part 101 have been approved under OMB control number 0910-
0381. The collections of information in 21 CFR 101.11 have been
approved under OMB control number 0910-0782.
III. Electronic Access
Persons with access to the internet may obtain the draft guidance
at https://www.fda.gov/FoodGuidances, https://www.fda.gov/regulatory-information/search-fda-guidance-documents, or https://www.regulations.gov. Use the FDA website listed in the previous
sentence to find the most current version of the guidance.
IV. References
The following references are on display at the Dockets Management
Staff (see ADDRESSES) and are available for viewing by interested
persons between 9 a.m. and 4 p.m., Monday through Friday; they are also
available electronically at https://www.regulations.gov. Although FDA
verified the website addresses in this document, please note that
websites are subject to change over time.
1. Harnack L.J., M.E. Cogswell, J.M. Shikany, et al. ``Sources of
Sodium in U.S. Adults From 3 Geographic Regions.'' Circulation, 135
(May 9, 2017): pp. 1775-1783. Available at: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.116.024446 (accessed
December 26, 2023).
2. U.S. Department of Agriculture and U.S. Department of Health and
Human Services. ``Dietary Guidelines for Americans, 2020-2025.'' 9th
Edition. December 2020. Available at: https://www.dietaryguidelines.gov/ (accessed December 26, 2023).
3. National Academies of Sciences, Engineering, and Medicine.
``Dietary Reference Intakes for Sodium and Potassium'' (March 2019).
Washington, DC: The National Academies Press. Available at: https://www.nationalacademies.org/hmd/Reports/2019/dietary-reference-intakes-sodium-potassium.aspx (accessed December 26, 2023).
Dated: August 9, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-18261 Filed 8-15-24; 8:45 am]
BILLING CODE 4164-01-P